Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The high global prevalence of type 2 diabetes continues to drive the demand for effective glucose-lowering agents like GLP-1 receptor agonists
GLP-1 drugs began being approved by the US Federal Drug Administration for use in Type 2 Diabetics in 2005.[3] Their impact has been tremendous
Warning: Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition
However, future research needs to conduct long-term follow-up and large sample studies to more comprehensively evaluate the cardiovascular effects of tirzepatide, validating its potential as a safe and effective treatment option for diabetes and heart disease
doi: 10.3389/fpsyt.2019.00207 41 JonesKSParkingtonDABourassaMWCeramiCKoulmanA
US$ 22.07
US$ 20.87
US$ 29.11
US$ 28.57
US$ 29.53
US$ 28.76
